A program to help patients with psychiatric disorders manage their insomnia
Become Your Own SLEEPexpert: a Behavioral Treatment Program for Insomnia in Patients With Psychiatric Disorders
This study is testing a special sleep program to help patients with serious mental health issues learn to manage their insomnia better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Bern Academic / other |
| Locations | 1 site (Bern) |
| Trial ID | NCT05408078 on ClinicalTrials.gov |
What this trial studies
This program aims to empower patients with severe mental disorders to manage their own sleep health through a behavioral treatment approach known as cognitive behavioral therapy for insomnia (CBT-I). The study will adapt CBT-I components to meet the specific needs of psychiatric inpatients, who often face challenges in accessing effective sleep treatments. Patients will be screened for insomnia severity and invited to participate in the program, which includes sleep monitoring and standard treatment practices. The goal is to evaluate the feasibility and efficacy of this tailored approach in an acute hospital setting.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a documented diagnosis of acute insomnia and currently admitted to a psychiatric ward.
Not a fit: Patients with severe cognitive impairments or acute psychiatric symptoms that prevent them from participating in the program will not benefit.
Why it matters
Potential benefit: If successful, this program could significantly improve sleep quality and overall mental health for patients with psychiatric disorders.
How similar studies have performed: Preliminary evidence suggests that similar approaches have shown feasibility and efficacy, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Documented diagnosis of acute insomnia, i.e. insomnia criteria according to ICD-10 for at least 2 weeks * Insomnia Severity Index (ISI) total score ≥ 8, equivalent to relevant insomnia * Inpatient in one of the two participating psychiatric wards in the UPD Bern * Ability to understand the aims and procedures of the study * Willingness to participate and ability to provide written informed consent Exclusion Criteria: * Incabability of judgement * Inability to participate in a low-threshold behavioral treatment program, e.g. due to severe cognitive impairment or high symptom severity precluding participation (e.g., severe catatonic symptoms, massive hallucinations, acute endangerment to self or others, involuntary commitment). Note that the named symptoms will lead to exclusion only if they lead to inability to give informed consent or an inability to participate in the program. Excluded patients will be re-assessed regularly and included if symptoms improve and participation is possible at a later point in time.
Where this trial is running
Bern
- University Hospital of Psychiatry and Psychotherapy — Bern, Switzerland (Recruiting)
Study contacts
- Principal investigator: Christoph Nissen, Prof.Dr. — University Hospital of Psychiatry and Psychotherapy
- Study coordinator: Christoph Nissen, Prof.Dr
- Email: Christoph.Nissen@hcuge.ch
- Phone: +41 31 930 9545
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.